Concepedia

Publication | Open Access

The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial

53

Citations

30

References

2017

Year

References

YearCitations

Page 1